Breakthrough MS drug tipped for blockbuster status
November 30, 2004The US has approved Tysabri, an innovative new drug which could offer new hope for sufferers of multiple sclerosis and …
Independent agencies band together in global network
November 26, 2004PAN Advertising has formed a global network of independent healthcare communications agencies they hope will allow them to challenge the …
AstraZeneca and CAT in long-term research partnership
November 24, 2004AstraZeneca has announced a five-year research and development alliance with Cambridge Antibody Technology for the joint discovery of antibody drugs, …
Leading by example
November 24, 2004Selling medicines has always been a complicated business. The end user of the new product is ultimately the patient, but …
Spearhead PCTs to tackle health inequality
November 23, 2004PCTs in some of England's most deprived areas are to lead a new drive to tackle public health problems such …
Strict new conflict of interest rules for MHRA proposed
November 19, 2004Growing concerns about the independence and transparency of the UK medicines regulator have been met by a set of strict …
Raptiva launched in first European markets
November 18, 2004Serono's new psoriasis treatment Raptiva has been launched in its first European markets, including the UK.The drug is licensed to …
Mutual medicine
November 18, 2004From developing strategy for a product at the earliest pre-launch phase to promoting older, established products the pharma industry has …
PR: the power of perceptions
November 3, 2004Pharma is taking an increasing interest in PR and what it can achieve in the marketing mix. But with a …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
